Cargando…
Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy
Molecular medicine has gained clinical relevance for the detection and staging of oncological diseases, to guide therapy decision making and for therapy follow-up due to the availability of new highly sensitive hybrid imaging camera systems and the development of new tailored radiopharmaceuticals th...
Autores principales: | Signore, Alberto, Lauri, Chiara, Auletta, Sveva, Varani, Michela, Onofrio, Livia, Glaudemans, Andor W. J. M., Panzuto, Francesco, Marchetti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226069/ https://www.ncbi.nlm.nih.gov/pubmed/32218303 http://dx.doi.org/10.3390/cancers12040781 |
Ejemplares similares
-
PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019) -
Immuno-Imaging to Predict Treatment Response in Infection, Inflammation and Oncology
por: Signore, Alberto, et al.
Publicado: (2019) -
State of the Art of Natural Killer Cell Imaging: A Systematic Review
por: Varani, Michela, et al.
Publicado: (2019) -
FDG-PET/CT in infections: the imaging method of choice?
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2010) -
Immune cell labelling and tracking: implications for adoptive cell transfer therapies
por: Galli, Filippo, et al.
Publicado: (2021)